Ault Global Holdings, Inc. (DPW)
Dopo ore:
| Chiusura precedente | 1,6300 |
| Aperto | 1,6200 |
| Denaro | 1,5100 x 2200 |
| Lettera | 1,5400 x 4000 |
| Min-Max giorno | 1,4800 - 1,6200 |
| Intervallo di 52 settimane | 1,4800 - 7,9900 |
| Volume | |
| Media Volume | 4.889.749 |
| Capitalizzazione | 122,888M |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 19 nov 2021 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
UPDATE - Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listingCHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, through an extensive, established European Union
- GlobeNewswire
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listingCHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, through an extensive, established European Union
